RELEUKO 300 ug/mL
Filgrastim · INJECTION, SOLUTION · Amneal Pharmaceuticals LLC
No Recall HistoryCurrently in Shortage
Plain English
RELEUKO is a injection, solution containing filgrastim at 300 ug/mL, taken intravenous. Manufactured by Amneal Pharmaceuticals LLC.
Key Facts
- Brand Name
- RELEUKO
- Generic Name
- Filgrastim
- NDC Code (Product)
70121-1569- Manufacturer
- Amneal Pharmaceuticals LLC
- Strength
- 300 ug/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761082
- Drug Class
- Leukocyte Growth Factor [EPC]
- Marketing Start
- 02/25/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is RELEUKO used for?
RELEUKO contains Filgrastim. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is RELEUKO a controlled substance?
RELEUKO is not classified as a controlled substance by the DEA.
What is the generic name for RELEUKO?
The generic name for RELEUKO is Filgrastim. There are 11 other brand versions of Filgrastim.
What is the NDC code for RELEUKO 300 ug/mL?
The NDC (National Drug Code) for RELEUKO 300 ug/mL is 70121-1569, listed by Amneal Pharmaceuticals LLC.